Javascript must be enabled to continue!
Complications of Hematologic Malignancies in the Emergency Department: A Primer for the Radiologist
View through CrossRef
Hematologic malignancies, including diseases such as Hodgkin and non-Hodgkin lymphoma, acute and chronic lymphocytic and myelogenous leukemia, and multiple myeloma, comprise a set of prevalent and clinically diverse diseases that can affect any organ system.1 Acute life-threatening oncologic emergencies can result secondary to the underlying disease or as a result of complications of therapy, and they are common in patients with hematologic malignancies. Oncologic emergencies can be categorized as metabolic, hematologic, and structural conditions.2 Although metabolic and hematologic emergencies are diagnosed most often on the basis of clinical and laboratory findings, imaging plays a significant role in determining the underlying cause for these entities. Imaging studies play a critical role in diagnosing structural pathologic conditions, which can result in bleeding, mechanical compression, or obstruction to the hollow organs. Radiologists should be aware of the acute clinical presentations of hematologic malignancies to make an accurate, timely diagnosis and provide appropriate patient care. This article reviews, in a systematic, organ-based approach, the acute metabolic and mechanical emergencies encountered in the emergency department in patients with hematologic malignancies.
Ovid Technologies (Wolters Kluwer Health)
Title: Complications of Hematologic Malignancies in the Emergency Department: A Primer for the Radiologist
Description:
Hematologic malignancies, including diseases such as Hodgkin and non-Hodgkin lymphoma, acute and chronic lymphocytic and myelogenous leukemia, and multiple myeloma, comprise a set of prevalent and clinically diverse diseases that can affect any organ system.
1 Acute life-threatening oncologic emergencies can result secondary to the underlying disease or as a result of complications of therapy, and they are common in patients with hematologic malignancies.
Oncologic emergencies can be categorized as metabolic, hematologic, and structural conditions.
2 Although metabolic and hematologic emergencies are diagnosed most often on the basis of clinical and laboratory findings, imaging plays a significant role in determining the underlying cause for these entities.
Imaging studies play a critical role in diagnosing structural pathologic conditions, which can result in bleeding, mechanical compression, or obstruction to the hollow organs.
Radiologists should be aware of the acute clinical presentations of hematologic malignancies to make an accurate, timely diagnosis and provide appropriate patient care.
This article reviews, in a systematic, organ-based approach, the acute metabolic and mechanical emergencies encountered in the emergency department in patients with hematologic malignancies.
Related Results
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
Iron Overload after Hematopoietic Stem Cell Transplantation
Iron Overload after Hematopoietic Stem Cell Transplantation
Abstract
Introduction Iron overload (IOL) is a common complication after HSCT, mainly due to iterative red blood cell (RBC) transfusions with other mechanisms as ine...
1378. Clinical Characteristics of Tuberculosis Among Patients with Cancer in an Endemic Country
1378. Clinical Characteristics of Tuberculosis Among Patients with Cancer in an Endemic Country
Abstract
Background
Tuberculosis (TB) is an infection caused by reactivation of Mycobacterium tuberculosis. Decreasing host immu...
Tetraspanins set the stage for bone marrow microenvironment–induced chemoprotection in hematologic malignancies
Tetraspanins set the stage for bone marrow microenvironment–induced chemoprotection in hematologic malignancies
Abstract
Despite recent advances in the treatment of hematologic malignancies, relapse still remains a consistent issue. One of the primary contributors to relapse i...
Categorizing Molecular Mutations in MDS and AML
Categorizing Molecular Mutations in MDS and AML
Abstract
Introduction:
A huge amount of data on genetic alterations has been compiled by high throughput sequencing studies in several hematologic mal...
High-Dose Vincristine Sulfate Liposome Injection (Marqibo®) Is Not Associated With Clinically Meaningful Hematologic Toxicity
High-Dose Vincristine Sulfate Liposome Injection (Marqibo®) Is Not Associated With Clinically Meaningful Hematologic Toxicity
Abstract
Background
The treatment of hematologic malignancy patients with heavily pre-treated, advanced, relapsed, or refractory...
AI and Incidental Findings
AI and Incidental Findings
Photo by Accuray on Unsplash
INTRODUCTION
Delayed and missed follow-up on incidental findings threatens patient health and is a major financial risk for healthcare systems. The hea...
Abstract 4371243: Analysis of Discrepancies Between Radiologist and AI CCTA Readings Across Clinical Thresholds
Abstract 4371243: Analysis of Discrepancies Between Radiologist and AI CCTA Readings Across Clinical Thresholds
Background:
CCTA informs clinical decisions with stenosis thresholds that guide treatment, testing, and insurance approval. AI-based tools may reduce interpreta...

